TRT Trio-Tech International
$10.10▲ +0.70%
Technology
Other
After hours
$10.10▲ +0.00%
Sep 11, 6:17 PM ET
Volume 87.3K
Avg Volume (10D) 133.6K
Key Metrics & Fundamentals
Market Cap
$104.67M
P/E Ratio
202.0
Div Yield
–%
52W Range
2.57 - 21.38
% vs 50 MA
-3.46%
% vs 200 MA
16.50%
RSI-14
44.8
MACD Histogram
-0.0300
Beta (1Y vs SPY)
1.83
Free Cash Flow
$707,000
Gross Rev
$16.51M
Gross Profit
$2.55M
EBITDA
$642,000
COGS
$13.96M
Operating Exp
$2.62M
Operating Income
-$70,000
EBIT
-$70,000
Pretax Income
$107,000
Net Income
-$38,000
EPS (Diluted)
0.00
Price & Volume History
Loading chart…
Recent News
Geospace Plunges Nearly 42% in 3 Months: How to Play the Stock?
Zacks · Sep 3, 2026 5:31 PM
Trio-Tech Stock Jumps Nearly 122% in 6 Months: What's Behind the Rally?
Zacks · Sep 2, 2026 5:25 PM
Trio-Tech International Approved for Listing on Nasdaq Global Market
Business Wire · Aug 19, 2026 12:30 PM
Trio-Tech International Receives Additional Orders for Burn-in Boards
MT Newswires · Jul 28, 2026 2:22 PM
Trio-Tech International Receives Additional $3.8 Million in Orders Supporting Next-Generation AI GPU Platform
Business Wire · Jul 28, 2026 12:30 PM
TRT vs. INTT: Which Semiconductor Testing Stock Is the Better Buy?
Zacks · Jul 13, 2026 4:24 PM
Trio-Tech Stock Surges 104.4% in 3 Months: What's Driving the Rally?
Zacks · Jun 25, 2026 3:40 PM
Zacks Initiates Coverage of Trio-Tech With Neutral Recommendation
Zacks · Jun 24, 2026 3:01 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See TRT's money flow as a full page
Social Sentiment
Avg -0.10 · 2 posts
DiscussionTradeBig Pharma Peptide investing
r/investing · Apr 28, 2026
The author is considering investing in Eli Lilly due to TRT's reported effectiveness.
positive
+0.60
Marinus Pharma (MRNS)
r/stocks · Dec 5, 2024
The comments express a negative outlook on the stock due to discontinued trial and suggest it’s a ‘money pit’.
negative
-0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.